コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 dducts with the C8 position of adenosine and guanosine.
2 hydrogen bonding and cation-coordination of guanosines.
4 R downstream signaling molecule cGMP (cyclic guanosine 3',5' monophosphate) from 0.91+/-0.3 to 3.1+/-
5 l class of peptidic hormones that signal via guanosine 3',5'-cyclic monophosphate (cGMP) and systemic
6 /PEL-negative individuals exhibited a normal guanosine 3',5'-cyclic monophosphate level, suggesting a
7 ty, leading to elevated intracellular cyclic guanosine 3',5'-monophosphate (cGMP) and subsequent vasc
10 ersion of guanosine triphosphate into cyclic guanosine-3',5'-monophosphate, a key second messenger in
11 Pharmacological studies using radiolabeled guanosine 5'-3-O-([(35)S]thio)triphosphate and [(3)H]ket
12 ed agonist Emax) in signaling events such as guanosine 5'-3-O-(thio)triphosphate binding and beta-arr
16 ular docking resulted into identification of guanosine 5'-diphosphate (GDP) as a promising hepcidin-b
17 plexes between K-Ras or the G12X mutants and guanosine 5'-diphosphate (GDP) or GDPnP (a stable GTP an
18 , we observed that in solution, farnesylated guanosine 5'-diphosphate (GDP)-bound K-Ras4B is predomin
19 review, we discuss newly elucidated roles of guanosine 5'-diphosphate 3'-diphosphate (ppGpp) in trans
21 onsequently, drugs targeting the inactive or guanosine 5'-diphosphate-bound conformation are not expe
23 of the enzymes involved in ppGpp, pppGpp and guanosine 5'-monophosphate 3'-diphosphate (pGpp) (collec
27 h end-binding protein 1 (EB1) for binding to guanosine 5'-O-[gamma-thio]triphosphate (GTPgammaS)-stab
28 initial hit, 36 showed improved potency in a guanosine 5'-O-[gamma-thio]triphosphate assay, exhibited
30 y redistribution and pinpoint why the TS for guanosine 5'-triphosphate (GTP) hydrolysis is higher in
31 s), proteins that catalyze the hydrolysis of guanosine 5'-triphosphate (GTP) to promote conformationa
32 ), Sec23-Sec24, and blocked upon addition of guanosine-5'-[(beta,gamma)-imido]triphosphate, a poorly
34 inone (H2Q), N-acetyl-tyrosine (N-Ac-Tyr) or guanosine-5'-monophosphate (GMP) was investigated at var
36 for potential existence of a third alarmone, guanosine-5'-monophosphate-3'-diphosphate (pGpp), with l
37 of the two enzymes, tyrosine hydroxylase and guanosine-5'-tri-phosphate-cyclohydrolase-1, bilaterally
40 r containing a template 8-oxo-7,8-dihydro-2'-guanosine (8OG) by Family X Polymerase mu (Pol mu) in st
41 nome encapsidation, indicating that unpaired guanosines act synergistically to promote packaging.
42 e using FSCV, which can be used to study the guanosine-adenosine interaction and better understand th
45 ions at their 5' end: an inverted methylated guanosine and a unique 2'O-methylation on the ribose of
48 c voltammetry (FSCV) has been used to detect guanosine and adenosine independently, but codetection h
50 We show the first method for codetecting guanosine and adenosine using FSCV, which can be used to
51 loped a novel "scalene waveform" to codetect guanosine and adenosine with nanomolar limits of detecti
53 ition unmodified 5'-(R)- and 5'-(S)-C-methyl guanosine and evaluation of these nucleotides in the con
57 phate, inosine monophosphate, adenosine, and guanosine) and kokumi (gamma-l-glutamyl-l-valine) taste-
58 lipid, and protein metabolisms, glutathione, guanosine, and L-glutamic acid, which are implicated in
59 identify METTL1-dependent N7-methylation of guanosine as a new RNA modification pathway that regulat
61 xamined the roles of single-stranded exposed guanosines at NC binding sites in RNA genome packaging u
63 lobacter-infecting phages, which replace all guanosine bases in the genome in a genus-specific manner
64 within a cellular setting, whereby cytosine-guanosine binding appeared to disrupt this cell-surface
65 ndicate that the PRNTase domain has a unique guanosine-binding mode different from that of eukaryotic
67 ulating levels of bis-(3',5')-cyclic-dimeric-guanosine (c-di-GMP), a second messenger that stimulates
68 ) catalyses the formation of a N7-methylated guanosine cap structure on the 5' end of nascent RNA pol
69 hat viral RNAs containing a single 5' capped guanosine ((Cap)1G) are specifically selected for packag
70 ed RNAs beginning with one, two, or three 5'-guanosines ((Cap)1G, (Cap)2G, or (Cap)3G, respectively)
71 n interchangeable and hierarchical nature of guanosine-containing sites, which was not previously est
72 tide combination of a cytosine followed by a guanosine (CpG), indicating that they are detrimental to
73 nthine dehydrogenase, nucleoside hydrolases, guanosine deaminase, and hypoxanthine guanine phosphorib
74 anthine, and that xanthosine is derived from guanosine deamination and a second source, likely xantho
75 Taken together, the results suggest that a guanosine-dependent metabolic switch determines the mode
76 (S-IIP) that is present only in the inactive guanosine diphosphate (GDP)-bound form of KRAS(G12C), sp
77 T2/6/7 has a modest preference for GTP- over guanosine diphosphate (GDP)-bound MT lattice and compete
82 dimeric conformations upon binding to GTP or guanosine diphosphate, and that the Parkinson's disease
86 of alternating non-templated uridine (U) and guanosine (G) ribonucleotides to the 3' termini of these
87 Thienoguanosine ((th)G) is an isomorphic guanosine (G) surrogate that almost perfectly mimics G i
88 an 10% of poly(A) tails contain at least one guanosine (G); among them, the G-content varies from 0.8
89 e of a pre-catalytic state of this RNA shows guanosine G40 and adenosine A32 close to the G53-U54 cle
94 udies demonstrate the importance of specific guanosines in HIV-2 5'UTR in mediating genome packaging.
95 at reveal that METTL1 N7-methylates internal guanosines in mRNAs and miRNAs to increase translation e
96 rus and HIV-1, we hypothesized that unpaired guanosines in the 5' untranslated region (UTR) play an i
97 Structural properties of 5'-(R)-C-methyl guanosine incorporated into an RNA octamer were analysed
98 s structure-for example, by incorporation of guanosine into poly(A)-inhibits deadenylation by both Pa
99 ch antiparallel strand assembly in which syn-guanosine is adjacent to the complex at the 5' end of th
101 ing of the second messenger ppGpp to inosine-guanosine kinase (Gsk) in E. coli modulates the levels o
103 improved malondialdehyde and 8-hydroxy-deoxy guanosine levels, and also deteriorated renal function.
107 c mRNAs generally possess a 5' end N7 methyl guanosine (m(7)G) cap that promotes their translation an
108 mRNAs) normally possess a 5' end N(7)-methyl guanosine (m(7)G) cap, a non-canonical 5' nicotinamide a
109 'ppp is capped by the addition of a 7-methyl guanosine (m7G) (Cap-0) and a 2'-O-methyl (2'-OMe) group
112 of a G-C base pair, explains how a single 5'-guanosine modifies the function of a ~9-kilobase HIV-1 t
113 osine interaction has been proposed in which guanosine modulates adenosine levels, and the two work t
114 second messenger bis-(3'-5')-cyclic-dimeric-guanosine monophosphate (c-di-GMP) acts as an innate imm
115 he bacterial second messenger cyclic dimeric guanosine monophosphate (c-di-GMP) by posttranscriptiona
118 e bacterial second messenger cyclic di-3',5'-guanosine monophosphate (c-di-GMP) is a key regulator of
120 3B (PDE3B), and a membrane-permeable cyclic guanosine monophosphate (cGMP) analog on KATP channel ac
122 ic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) are now recognized as imp
123 m in dogs that results in lower basal cyclic guanosine monophosphate (cGMP) concentrations than in wi
124 duction of the second messenger 3',5'-cyclic guanosine monophosphate (cGMP) have been shown to protec
125 trength and fluorescence response for cyclic guanosine monophosphate (cGMP) in an aqueous solution.
126 9-I dose-dependently increased plasma cyclic guanosine monophosphate (cGMP) in normal sheep (p < 0.05
127 Phosphodiesterase 5 (PDE5) hydrolyzes cyclic guanosine monophosphate (cGMP) leading to increased leve
128 tive (soluble) guanylyl cyclase (sGC)-cyclic guanosine monophosphate (cGMP) pathway regulates diverse
130 itric oxide pathway effector molecule cyclic guanosine monophosphate (cGMP), has been implicated in t
131 ic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), is preferentially expres
132 ownstream target of sildenafil in the cyclic guanosine monophosphate (cGMP)-activated protein kinase
134 reas the response to ascr#3 relies on cyclic guanosine monophosphate (cGMP)-gated channels and activi
139 riggers the innate immune response is cyclic guanosine monophosphate (GMP)-adenosine monophosphate (A
142 Other strategies to increase tissue cyclic guanosine monophosphate have been attempted, such as PDE
147 We further demonstrate that the gene for guanosine monophosphate reductase (GMPR) is a direct MIT
148 sphodiesterase-5 inhibitors and other cyclic guanosine monophosphate signaling activators worked syne
149 d treatment with N-acetylcysteine and cyclic guanosine monophosphate signaling enhancers warrants fur
151 guanosine triphosphate to cGMP (cyclic 3',5'-guanosine monophosphate) on binding of ANP, BNP (atrial
152 ssenger c-di-GMP (Bis-(3'-5')-cyclic dimeric guanosine monophosphate), to make a vital choice: whethe
153 , Na2 [(HGMP)2 Mo5 O15 ]7 H2 O (1; where GMP=guanosine monophosphate), which spontaneously assembles
155 phodiesterases (PDEs), which degrade cGMP to guanosine monophosphate, play key role in controlling th
156 -treated kidneys had higher levels of cyclic guanosine monophosphate, potentially explaining the perf
157 the synthesis of a second messenger, cyclic guanosine monophosphate-adenosine monophosphate (2'3'-cG
159 Here we show that cytoplasmic sensor cyclic guanosine monophosphate-adenosine monophosphate (AMP) sy
160 tin without linker histone stimulates cyclic guanosine monophosphate-adenosine monophosphate (cGAMP)
162 led that SR-717 functions as a direct cyclic guanosine monophosphate-adenosine monophosphate (cGAMP)
163 mimetic liposomes encapsulating 2',3'-cyclic guanosine monophosphate-adenosine monophosphate (cGAMP),
164 endogenous CDN ligand for STING, 2'3' cyclic guanosine monophosphate-adenosine monophosphate (cGAMP).
165 ed liposome loaded with STING agonist cyclic guanosine monophosphate-adenosine monophosphate (NP-cGAM
166 a pathway dependent on the DNA sensor cyclic guanosine monophosphate-adenosine monophosphate synthase
167 ed an altered distribution of nuclear cyclic guanosine monophosphate-adenosine monophosphate synthase
169 riggered activation of the DNA sensor cyclic guanosine monophosphate-adenosine monophosphate synthase
172 the same for both nucleotides, suggesting a guanosine nucleoside or ribose-first mechanism for nucle
176 RL13b) is a small GTPase that functions as a guanosine nucleotide exchange factor (GEF) for ARL3-GDP.
178 nt paradigm holds that the inhibition of Rho guanosine nucleotide exchange factors (GEFs), the enzyme
181 reviously reported IMPDH complexes harboring guanosine nucleotides at the second canonical site, TbIM
183 Rel proteins synthesize hyperphosphorylated guanosine nucleotides, denoted as (p)ppGpp, which by inh
185 receptor 9 (TLR9) agonist cytidine-phosphate-guanosine oligodeoxynucleotide (CpG) to determine effect
186 ), the Toll-like-receptor-9 agonist cytosine-guanosine oligodeoxynucleotide and one or multiple leuka
187 e ligands include phosphorothioated cytosine-guanosine oligonucleotides, a motif often seen in bacter
191 at is dependent on the UvrD helicase and the guanosine pentaphosphate (ppGpp) alarmone/stringent resp
193 armones guanosine tetraphosphate (ppGpp) and guanosine pentaphosphate (pppGpp) in response to nutrien
194 s tested in this report, substituting 3 to 4 guanosines resulted in <2-fold defects in packaging.
198 ely spaced runs of three or more consecutive guanosines strongly tend to fold into stable G-quadruple
200 ine monophasphate dehydrogenase dedicated to guanosine synthesis, GuaB2, displayed the opposite expre
201 signalling system mediated by the alarmones guanosine tetraphosphate (ppGpp) and guanosine pentaphos
202 t has been linked to this persister state is guanosine tetraphosphate (ppGpp), the alarmone that was
206 repair, at the mRNA level, a disease-causing guanosine to adenosine (G > A) mutation in the mouse MeC
207 ters containing a family of paralogs of tRNA guanosine transglycosylase genes, called tgtA5, alongsid
208 nthesizing enzymes, tyrosine hydroxylase and guanosine-tri-phosphate-cyclohydrolase-1, offers a new a
209 in complex 1 (mTORC1) protein kinase via its guanosine triphosphatase (GTPase) activating protein (GA
210 eins are constitutively active because their guanosine triphosphatase (GTPase) activity is disabled.
212 erestingly, ciliary trafficking of the small guanosine triphosphatase (GTPase) Arl13b, loss of which
214 During mitochondrial division, the mechano-guanosine triphosphatase (GTPase) dynamin-related protei
215 s targeting KRAS(G12C), a mutant form of the guanosine triphosphatase (GTPase) KRAS, are a promising
216 ornavirus infection was a large set encoding guanosine triphosphatase (GTPase) of immunity-associated
219 ration and cell migration, whereas the small guanosine triphosphatase (GTPase) Rac1 mediates cell mig
220 ly of heterotrimeric G proteins to the small guanosine triphosphatase (GTPase) RhoA, enabling Galpha(
221 ein synthesis, elongation factor G (EF-G), a guanosine triphosphatase (GTPase), binds to the ribosoma
222 re its Raptor subunit interacts with the Rag guanosine triphosphatase (GTPase)-Ragulator complex.
224 , and CTNNB1 (encoding beta-catenin) and RHO guanosine triphosphatase [RHO GTPase, RHO], two signalin
228 is issue, Rafiq et al. reveal that the small guanosine triphosphatase ARF1, a well-known orchestrator
230 e cortical PAR proteins (including the small guanosine triphosphatase CDC-42) have an active role in
231 on is a multistep process facilitated by the guanosine triphosphatase elongation factor (EF)-Tu.
232 es bound to tRNAs, nascent polypeptides, the guanosine triphosphatase elongation factors mtEF-Tu and
234 Proteolytic cleavage of the dynamin-like guanosine triphosphatase OPA1 in mitochondria is emergin
236 l adhesion reduction by activating the small guanosine triphosphatase Ras homolog family member J by
238 show that mouse embryos that lack the small guanosine triphosphatase RSG1 die at embryonic day 12.5,
240 -membrane receptor for DRP1, the cytoplasmic guanosine triphosphatase that catalyzes mitochondrial fi
241 echanistically distinct enzymes (a kinase, a guanosine triphosphatase, and a ubiquitin protein hydrol
242 pecifically binds to the IQ motif-containing guanosine triphosphatase-activating protein 1 (IQGAP1) s
243 ng the genes small ARF GAP1 (SMAP1), an ARF6 guanosine triphosphatase-activating protein that functio
244 C1 is activated on lysosomes by Rag and Rheb guanosine triphosphatases (GTPases) and drives biosynthe
245 (mTORC1) is recruited to the lysosome by Rag guanosine triphosphatases (GTPases) and regulates anabol
247 yclical activation and inactivation of small guanosine triphosphatases (GTPases) by their specific gu
249 creasing the activity of the recycling small guanosine triphosphatases (GTPases) Rab4 or Rab11 was su
251 al cells, signaling pathways involving small guanosine triphosphatases (GTPases) regulate cell polari
254 involving the Ragulator complex and the Rag guanosine triphosphatases (GTPases), causing release of
255 e group of proteins, the Rho family of small guanosine triphosphatases (GTPases), is critical for thi
256 ce of RIT1 to other members of the Ras small guanosine triphosphatases (GTPases), mutations affecting
258 These processes all involve Rho family small guanosine triphosphatases (GTPases), which are regulated
260 nse proteins, including interferon-inducible guanosine triphosphatases and the antimicrobial cathelic
261 importance and activates mTORC1 via the Rag guanosine triphosphatases and their regulators GATOR1 an
262 d into motility signaling proteins (kinases, guanosine triphosphatases, and guanine exchange factors)
265 tyrosine kinase (RTK) ligands increase RhoA-guanosine triphosphate (GTP) in untransformed and transf
266 rtical motor complexes that depends on a Ran-guanosine triphosphate (GTP) signal [12], which is suffi
269 d the availability of ATP, which regenerates guanosine triphosphate (GTP), powers ribosomes, and prom
270 heir reduced intrinsic rate of hydrolysis of guanosine triphosphate (GTP), which results in their acc
271 he authors demonstrate that TBSV co-opts the guanosine triphosphate (GTP)-bound active form of the en
273 C2[E62K] displayed characteristics of active guanosine triphosphate (GTP)-bound RAC2 including enhanc
275 activated and deactivated for assembly by a guanosine triphosphate (GTP)-driven reaction cycle, and
276 s sustained by karyopherins (Kaps) and a Ran guanosine triphosphate (RanGTP) gradient that imports nu
277 d, and escort NLS-NCs through NPCs while Ran guanosine triphosphate (RanGTP) promotes their release f
278 ll polarity in the context of elevated Cdc42-guanosine triphosphate activity, similar to nonmalignant
279 App, and an associated depletion of cellular guanosine triphosphate and adenosine triphosphate pools,
280 otein synthesis via assembly of the 7-methyl-guanosine triphosphate cap-dependent translation complex
281 properties, including the requirement for a guanosine triphosphate cofactor and the generation of lo
283 egulates actin (dis-)assembly, and catalytic guanosine triphosphate hydrolysis is found in tubulin (d
284 te cyclase (sGC) catalyzes the conversion of guanosine triphosphate into cyclic guanosine-3',5'-monop
286 BB, which are associated with CDC42, a small guanosine triphosphate protein linked to T-cell activati
287 Resting and activated sGC enzyme converts guanosine triphosphate to an important second messenger
288 -A catalyzes the intracellular conversion of guanosine triphosphate to cGMP (cyclic 3',5'-guanosine m
289 the conformational change of EF-Tu from the guanosine triphosphate to guanine diphosphate conformati
290 at microtubules elongate by addition of bent guanosine triphosphate tubulin to the tips of curving pr
291 gnaling by converting active Ras is bound to guanosine triphosphate, activating Ras into inactive Ras
292 t retain the intrinsic capacity to hydrolyze guanosine triphosphate, suggesting that the mechanism of
294 l-length Trio, led to increased abundance of guanosine triphosphate-bound RhoA (RhoA.GTP) in human ce
296 uses the widely available starting material guanosine via a short sequence ending in a Mukaiyama hyd
298 rmation of ANKRD9/IMPDH2 rods is reversed by guanosine, which restores ANKRD9 associations with the v
299 sis of a photocaged nucleotide that releases guanosine within microseconds upon photosolvolysis with